You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

p53 mutant

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Cancers Trial in Houston (MLN9708, Vorinostat)

Completed
  • Advanced Cancers
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jul 8, 2022

Colorectal Cancer Metastatic Trial in Boston (Lamivudine)

Active, not recruiting
Has Results
  • Colorectal Cancer Metastatic
  • Boston, Massachusetts
    Massachusetts general Hospital
Aug 25, 2021

Endometrial Cancer, Serous Tumor, P53 Mutation Trial in Toronto (Cisplatin, External Beam Radiation, Carboplatin)

Recruiting
  • Endometrial Cancer
  • +2 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
May 20, 2021

P53 Mutation, Myeloid Malignancy, MDS Trial in Shanghai (Decitabine, Arsenic Trioxide)

Recruiting
  • P53 Mutation
  • +3 more
  • Shanghai, Shanghai, China
    Hematological department, Shanghai Institute of Hematology, Ruij
Apr 20, 2021

Colorectal Carcinoma, Ulcerative Colitis Trial in Chicago (Atorvastatin Calcium, Biospecimen Collection, Placebo Administration)

Recruiting
  • Colorectal Carcinoma
  • Ulcerative Colitis
  • Atorvastatin Calcium
  • +2 more
  • Chicago, Illinois
    Northwestern University
Feb 10, 2022

Pediatric Cancer, Li-Fraumeni Syndrome, p53 Mutations Trial in Guangzhou (Arsenic trioxide)

Not yet recruiting
  • Pediatric Cancer
  • +2 more
  • Arsenic trioxide
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Oct 12, 2023

Oesophageal Carcinoma Trial in Australia (APR-246)

Terminated
  • Oesophageal Carcinoma
  • Clayton, Victoria, Australia
  • +4 more
Dec 10, 2021

NSCLC, NSCLC Trial in Guangzhou (Apatinib + Fluzoparib, Apatinib + Fluzoparib + Adebrelimab)

Not yet recruiting
  • NSCLC
  • Non-small Cell Lung Cancer
  • Apatinib + Fluzoparib
  • Apatinib + Fluzoparib + Adebrelimab
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Jun 27, 2023

Solid Tumor, Adult, Lymphoma, EphA2 Overexpression Trial in Beijing (TP53-EphA-2-CAR-DC, Abraxane, Cyclophosphamide)

Recruiting
  • Solid Tumor, Adult
  • +6 more
  • TP53-EphA-2-CAR-DC
  • +3 more
  • Beijing, Beijing, China
    Biotherapeutic Department of Chinsese PLA Gereral Hospital
Nov 29, 2022

Infiltrating Duct Carcinoma of the Breast

Not yet recruiting
  • Invasive Breast Cancer
    • (no location specified)
    Jan 28, 2023

    Relapsing-remitting Multiple Sclerosis Trial (CT-P53, US-Ocrevus, EU-Ocrevus)

    Not yet recruiting
    • Relapsing-remitting Multiple Sclerosis
    • CT-P53
    • +2 more
    • (no location specified)
    Jun 7, 2023

    SNPs in p53 and p53 Response Elements on Inflammatory Response

    Completed
    • HIV-1 Seropositive
    • +3 more
      • Research Triangle Park, North Carolina
        NIEHS Clinical Research Unit (CRU)
      Jan 21, 2023

      MDS, MDS Trial in Tampa, Boston, Houston (APR-548 + Azacitidine)

      Terminated
      • MDS
      • Myelodysplastic Syndromes
      • APR-548 + Azacitidine
      • Tampa, Florida
      • +3 more
      Jul 20, 2022

      P53 Immunohistochemistry Abnormal Staining in Endometrial Cancer

      Completed
      • Endometrial Cancer
      • p 53 immunohistochemistry positive staining and relation to stages ,pathological types and grading
      • Alexandria, Egypt
        Hossam Hassan El Sokkary
      Sep 13, 2022

      Non Small Cell Lung Cancer Trial in Italy (Osimertinib)

      Recruiting
      • Non Small Cell Lung Cancer
      • Ancona, Italy
      • +10 more
      Mar 14, 2023

      Diffuse Large B Cell Lymphoma Trial in Wuhan (Zanubrutinib plus RCHOP)

      Recruiting
      • Diffuse Large B Cell Lymphoma
      • Zanubrutinib plus RCHOP
      • Wuhan, Hubei, China
        Union Hospital, Tongji Medical College, Huazhong University of S
      Aug 16, 2023

      Tumors, Ovarian Cancer, Breast Cancer Trial in Houston (ZN-c3, Bevacizumab, Pembrolizumab)

      Not yet recruiting
      • Tumors
      • +4 more
      • Houston, Texas
        MD Anderson Cancer Center
      Jun 20, 2022

      Endometrial Cancer Trial (Vaginal brachytherapy, Adjuvant radiotherapy (EBRT +/- brachytherapy), Observation)

      Not yet recruiting
      • Endometrial Cancer
      • Vaginal brachytherapy
      • +2 more
      • (no location specified)
      Nov 29, 2022

      Multiple Myeloma Trial in Tianjin (anti-BCMA CAR-T, Selinexor-VRD)

      Recruiting
      • Multiple Myeloma
      • Tianjin, China
        Institute of Hematology and Blood Diseases Hospital Chinese Acad
      May 12, 2023

      Unusual Infiltrative Patterns of Malignant Cells in Endometrial

      Not yet recruiting
      • Endometrial Cancer
        • (no location specified)
        Mar 11, 2023

        Colorectal Cancer Trial in Salt Lake City (Cetuximab)

        Recruiting
        • Colorectal Cancer
        • Salt Lake City, Utah
        • +1 more
        May 3, 2022

        Secondary Obliteration of Old Radical Cavities Using S53P4

        Recruiting
        • Mastoid Cavity
        • S53P4 bioactive glass granules
        • Utrecht, Netherlands
          Diakonessenhuis
        Nov 1, 2023

        Endometrial Cancer Trial (Paclitaxel, Carboplatin, Cisplatin)

        Not yet recruiting
        • Endometrial Cancer
        • (no location specified)
        Aug 4, 2022

        Advanced Solid Tumor Trial in Shanghai (SY-5933)

        Recruiting
        • Advanced Solid Tumor
        • Shanghai, China
          Shanghai Pulmonary Hospital
        Aug 16, 2023

        Locally Advanced Cervical Cancer Trial in Mexico City (Curcumin, Curcumin + Piperine)

        Recruiting
        • Locally Advanced Cervical Cancer
        • Curcumin
        • Curcumin + Piperine
        • Mexico City, Mexico
          Instituto Nacional de Cancerología
        Oct 6, 2023